Brief: Palatin Technologies To Develop Pl8177 As A Potential Treatment For Covid-19

Palatin Technologies

23/06/2020 12:43

June 23 (Reuters) - Palatin Technologies Inc  PTN.A :
    * PALATIN TECHNOLOGIES TO DEVELOP PL8177 AS A POTENTIAL
TREATMENT
FOR COVID-19 AND ASSOCIATED LUNG COMPLICATIONS
    * PALATIN TECHNOLOGIES - PALATIN IS PURSUING MULTIPLE
SOURCES FOR
RESEARCH AND DEVELOPMENT GRANTS TO SUPPORT PL8177 CLINICAL
DEVELOPMENT
    * PALATIN TECHNOLOGIES -  PLANNING TO SUBMIT AN IND FOR
PL8177 IN
Q3 & PLANNING PHASE 2 CLINICAL TRIAL INITIATION IN Q4 OF
CALENDAR YEAR 2020

Source text for Eikon:  ID:nPn1yCwPMa 
Further company coverage:  PTN.A 

 ((Reuters.Briefs@thomsonreuters.com;))